Table 4.
Studies included in the 2017 and 2019 Meta-analyses of Studies Examining Skeletal Health in Transgender Individuals.
| Studies included in 2017 Systematic Review [35] | ||||||
|---|---|---|---|---|---|---|
| Study | Country | Design | Patients | N | Mean Age (years) | Duration |
| Dittrich 2005 | Germany | Cohort | Transgender women | 60 | 38.37 | 24 mos |
| Klink 2015 | Netherlands | Cohort | Transgender women/Transgender men | 15/19 | 14.9/15 | 7.1/6.9 yrs |
| Mueller 2011 | Germany | Cohort | Transgender women | 84 | 36.3 | 24 mos |
| Mueller 2010 | Germany | Cohort | Transgender men | 45 | 30.4 | 12 and 24 mos |
| Pelusi 2014 | Italy | Cohort | Transgender men | 45 | 29.4 | 12 mos |
| Reutraku1998 | Thailand | Cohort | Transgender women | 11 | 21.2 | <24 mos |
| Sosa 2003 | Spain | Cohort | Transgender women | 17/27 | 24.1/43 | >24 mos |
| Turner2004 | USA | Cohort | Transgender men | 8 | 33.1 | 24 mos |
| VanCaenegem 2015 | Belgium | Cohort | Transgender men/Transgender women | 23/49 | 27/33 | 12 and 24 mos |
| VanCaenegem 1996 | Belgium | Cohort | Transgender women/Transgender men | 56/35 | 33/25 | 12 mos |
| VanCaenegem 1998 | Netherlands | Cohort | Transgender women/Transgender men | 20/19 | 25.4/25 | 45.5/38.2 mos |
| Wierckx 2014 | Belgium | Cohort | Transgender women | 47/6 | 31.7/19.3 | 12 mos |
| Wierckx 2014 |
Belgium |
Cohort |
Transgender men |
27/26 |
27.3/21.7 |
12 mos |
| Additional Studies included in 2019 Systematic Review [36] | ||||||
|
Study |
Country |
Design |
Patients |
N |
Mean Age (years) |
Duration |
| Haraldsen 2007 | Norway | Cohort | Transgender men/Transgender women | 21/12 | 25.1/29.3 | 12 mos |
| Wiepjes 2017 | Belgium | Cohort | Transgender men/Transgender women | 199/231 | 23.9/22.5 | 12 mos |
| Gava 2016 | Italy | Cohort | Transgender women | 40 | 32.9 | 12 mos |
| Fighera 2018 | Brazil | Cohort | Transgender women | 46 | 33.7 | 31 mos |
| Van Kesteren 1996 | Netherlands | Cohort | Transgender men/Transgender women | 35/56 | 25/33 | 12 mos |
| Van Kesteren 1998 | Netherlands | Cohort | Transgender men/Transgender women | 19/20 | 25/25.4 | 38.2 mos |
Abbreviations: mos, months; yrs, years.
Adapted and expanded from Singh-Ospina N et al. J Clin Endocrinol Metab. 2017 [35].